Sign inGet started

Mattila Jyrki

Insider CIK 1297318 · LPCN Chief Business Officer · REPH Executive VP, Business Dev. · BSTC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BSTC BIOSPECIFICS TECHNOLOGIES M Exercise deriv2019-05-222019-05-2415,000— $00SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES M Exercise deriv2019-05-222019-05-243,750— $011,250SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES S Sale2019-05-222019-05-2418,750$62.06 $1.16M376SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES M Exercise2019-05-222019-05-243,750$41.82 $156.8K19,126SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES M Exercise2019-05-222019-05-2415,000$37.64 $564.6K15,376SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES A Award deriv2018-03-152018-03-1915,000— $015,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2018-01-022018-01-0423,000— $023,000SEC↗
REPH Recro Pharma, Inc. A Award2018-01-022018-01-0411,500— $011,500SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-08-212017-08-2112,000— $012,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-08-212017-08-2175,000— $075,000SEC↗
LPCN Lipocine Inc. A Award deriv2017-01-262017-01-3015,000— $015,000SEC↗
LPCN Lipocine Inc. A Award deriv2016-12-072016-12-0840,000$3.61 $144.4K40,000SEC↗
LPCN Lipocine Inc. A Award deriv2016-01-052016-01-0740,000$12.92 $516.8K40,000SEC↗
LPCN Lipocine Inc. A Award deriv2015-06-112015-06-1510,000— $090,000SEC↗
LPCN Lipocine Inc. A Award deriv2015-05-152015-05-1880,000— $080,000SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES A Award deriv2015-04-222015-04-2315,000— $015,000SEC↗
BSTC BIOSPECIFICS TECHNOLOGIES A Award deriv2015-04-222015-06-2215,000— $015,000SEC↗